Oral Presentation at EULAR 2024 of Data from Global Phase 2b Clinical Trial Demonstrates Durability of Pain Relief After a Single Injection of MM-II in Patients with Painful Knee Osteoarthritis (OA)

A single intra-articular injection of 3mL of MM-II provided greater pain relief than placebo for up to 26 weeks From weeks 12 to 26, more patients on MM-II experienced a ≥50% improvement in knee OA pain than patients on placebo and used less rescue medication MUMBAI, India and TEL AVIV,…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.